Plain-English translation of NCT06570213 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our PTSD research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing whether combining two treatments—a procedure called a (a nerve injection in the neck) and Cognitive Processing Therapy (a proven talk therapy for trauma)—works better together than either one alone for people with PTSD. The nerve injection is meant to calm your body's stress response, while the talk therapy helps you process and challenge unhelpful beliefs about your trauma. Researchers want to see if combining them leads to greater improvement in PTSD symptoms.
Current treatments for PTSD help many people, but not everyone gets relief—and recovery can take a long time. This trial explores whether the medication can enhance the benefits of talk therapy by calming the nervous system while you work through trauma memories, potentially offering faster or more complete healing.
You likely qualify if…
You likely don't qualify if…
You would receive two injections (either the real treatment or a placebo salt water injection) two weeks apart at a pain clinic. After your first injection, you'll spend one week doing either 10 intensive sessions of trauma-focused talk therapy or daily check-ins with study staff to monitor your symptoms. You'll also complete questionnaires and assessments at multiple time points over six months to track how you're doing. Overall, the study involves clinic visits, some intensive daily sessions early on, and regular follow-up appointments.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States